The Role of Iron Overload in Diabetic Cognitive Impairment: A Review

References

• Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–2469. doi:10.1007/s00125-005-0023-4
   PubMed Web of Science ®Google Scholar
• Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329–340. doi:10.1016/S1474-4422(14)70249-2
   PubMed Web of Science ®Google Scholar
• McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–2299. doi:10.1016/S0140-6736(12)60360-2
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Sharrett AR, Schneider AL, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161(11):785–793. doi:10.7326/M14-0737
   PubMed Web of Science ®Google Scholar
• Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 2011;34(5):1102–1108. doi:10.2337/dc10-1333
   PubMed Web of Science ®Google Scholar
• Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M. Parkinson’s disease, diabetes and cognitive impairment. Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11–21. doi:10.2174/1872214810999160628105549
   PubMed Web of Science ®Google Scholar
• Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819–828. doi:10.1016/S1474-4422(11)70072-2
   PubMed Web of Science ®Google Scholar
• Sheftel AD, Mason AB, Ponka P. The long history of iron in the Universe and in health and disease. Biochim Biophys Acta. 2012;1820(3):161–187. doi:10.1016/j.bbagen.2011.08.002
   PubMed Web of Science ®Google Scholar
• Milto IV, Suhodolo IV, Prokopieva VD, Klimenteva TK. Molecular and cellular bases of iron metabolism in humans. Biochemistry. 2016;81(6):549–564. doi:10.1134/S0006297916060018
   PubMed Web of Science ®Google Scholar
• Gao H, Yang J, Pan W, Yang M. Iron overload and the risk of diabetes in the general population: results of the Chinese health and nutrition survey cohort study. Diabetes Metab J. 2022;46(2):307–318. doi:10.4093/dmj.2020.0287
   PubMed Web of Science ®Google Scholar
• Harrison AV, Lorenzo FR, McClain DA. Iron and the Pathophysiology of Diabetes. Annu Rev Physiol. 2023;85:339–362. doi:10.1146/annurev-physiol-022522-102832
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care. 2007;30(7):1926–1933. doi:10.2337/dc06-2625
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta. 2009;1790(7):671–681. doi:10.1016/j.bbagen.2008.04.005
   PubMed Web of Science ®Google Scholar
• Sampaio AF, Silva M, Dornas WC, et al. Iron toxicity mediated by oxidative stress enhances tissue damage in an animal model of diabetes. Biometals. 2014;27(2):349–361. doi:10.1007/s10534-014-9717-8
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Kodai S, et al. Iron restriction improves type 2 diabetes mellitus in otsuka long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab. 2010;298(6):E1140–9. doi:10.1152/ajpendo.00620.2009
   PubMed Web of Science ®Google Scholar
• Geng W, Pan L, Shen L, et al. Evaluating renal iron overload in diabetes mellitus by blood oxygen level-dependent magnetic resonance imaging: a longitudinal experimental study. BMC Med Imaging. 2022;22(1):200. doi:10.1186/s12880-022-00939-7
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang Y, Sun N, et al. MRI-measured myocardial iron load in patients with severe diabetic heart failure. Clin Radiol. 2018;73(3):324 e1–324 e7. doi:10.1016/j.crad.2017.10.012
   PubMed Web of Science ®Google Scholar
• Zhang WL, Meng HZ, Yang MW. Regulation of DMT1 on bone microstructure in type 2 diabetes. Int J Med Sci. 2015;12(5):441–449. doi:10.7150/ijms.11986
   PubMed Web of Science ®Google Scholar
• An JR, Su JN, Sun GY, et al. Liraglutide alleviates cognitive deficit in db/db Mice: involvement in oxidative stress, iron overload, and ferroptosis. Neurochem Res. 2022;47(2):279–294. doi:10.1007/s11064-021-03442-7
   PubMed Web of Science ®Google Scholar
• Gozzelino R, Arosio P. Iron homeostasis in health and disease. Int J Mol Sci. 2016;17(1):130. doi:10.3390/ijms17010130
   PubMed Web of Science ®Google Scholar
• Hofer T, Perry G. Nucleic acid oxidative damage in Alzheimer’s disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? J Trace Elem Med Biol. 2016;38:1–9. doi:10.1016/j.jtemb.2016.06.005
   PubMed Web of Science ®Google Scholar
• Knierim JJ. The hippocampus. Curr Biol. 2015;25(23):R1116–21. doi:10.1016/j.cub.2015.10.049
   PubMed Web of Science ®Google Scholar
• Milne NT, Bucks RS, Davis WA, et al. Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus. Brain Behav. 2018;8(1):e00741. doi:10.1002/brb3.741
   PubMed Web of Science ®Google Scholar
• Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, Reagan LP. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience. 2005;136(2):477–486. doi:10.1016/j.neuroscience.2005.08.019
   PubMed Web of Science ®Google Scholar
• Hao L, Mi J, Song L, et al. SLC40A1 mediates ferroptosis and cognitive dysfunction in type 1 diabetes. Neuroscience. 2021;463:216–226. doi:10.1016/j.neuroscience.2021.03.009
   PubMed Web of Science ®Google Scholar
• Tang W, Li Y, He S, et al. Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid Redox Signal. 2022;37(13–15):867–886. doi:10.1089/ars.2021.0233
   PubMed Web of Science ®Google Scholar
• Soltesz I, Losonczy A. CA1 pyramidal cell diversity enabling parallel information processing in the hippocampus. Nat Neurosci. 2018;21(4):484–493. doi:10.1038/s41593-018-0118-0
   PubMed Web of Science ®Google Scholar
• Xie Z, Wang X, Luo X, et al. Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis. Biochem Pharmacol. 2023;207:115374. doi:10.1016/j.bcp.2022.115374
   PubMed Web of Science ®Google Scholar
• An JR, Liu JT, Gao XM, et al. Effects of liraglutide on astrocyte polarization and neuroinflammation in db/db mice: focus on iron overload and oxidative stress. Front Cell Neurosci. 2023;17:1136070. doi:10.3389/fncel.2023.1136070
   PubMed Web of Science ®Google Scholar
• Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res. 2007;32(11):1884–1890. doi:10.1007/s11064-007-9375-0
   PubMed Web of Science ®Google Scholar
• Gholamhosseinian A, Abbasalipourkabir R, Ziamajidi N, Sayadi M, Sayadi K. The anti-inflammatory effect of omega-3 polyunsaturated fatty acids dramatically decreases by iron in the hippocampus of diabetic rats. Life Sci. 2020;245:117393. doi:10.1016/j.lfs.2020.117393
   PubMed Web of Science ®Google Scholar
• Hedden T, Gabrieli JD. Shared and selective neural correlates of inhibition, facilitation, and shifting processes during executive control. Neuroimage. 2010;51(1):421–431. doi:10.1016/j.neuroimage.2010.01.089
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhou L, Liu C, et al. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study. Brain Imaging Behav. 2018;12(5):1479–1487. doi:10.1007/s11682-017-9815-7
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Q, Zhang N, Guo L. Increased brain iron deposition in the putamen in patients with type 2 diabetes mellitus detected by quantitative susceptibility mapping. J Diabetes Res. 2020;2020:7242530. doi:10.1155/2020/7242530
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Q, Zhang N, Guo L. Increased brain iron detection by voxel-based quantitative susceptibility mapping in type 2 diabetes mellitus patients with an executive function decline. Front Neurosci. 2020;14:606182. doi:10.3389/fnins.2020.606182
   PubMed Web of Science ®Google Scholar
• Pandur E, Szabo I, Hormay E, et al. Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model. Diabetol Metab Syndr. 2022;14(1):147. doi:10.1186/s13098-022-00919-5
   PubMed Web of Science ®Google Scholar
• Mechlovich D, Amit T, Bar-Am O, Weinreb O, Youdim MB. Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus. Br J Pharmacol. 2014;171(24):5636–5649. doi:10.1111/bph.12862
   PubMed Web of Science ®Google Scholar
• McCarthy RC, Kosman DJ. Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier. Front Mol Neurosci. 2015;8:31. doi:10.3389/fnmol.2015.00031
   PubMed Web of Science ®Google Scholar
• McCarthy RC, Kosman DJ. Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. Cell Mol Life Sci. 2015;72(4):709–727. doi:10.1007/s00018-014-1771-4
   PubMed Web of Science ®Google Scholar
• Dusek P, Hofer T, Alexander J, Roos PM, Aaseth JO. cerebral iron deposition in neurodegeneration. Biomolecules. 2022;12(5):714. doi:10.3390/biom12050714
   PubMed Web of Science ®Google Scholar
• Brock JH. Lactoferrin--50 years on. Biochem Cell Biol. 2012;90(3):245–251. doi:10.1139/o2012-018
   PubMed Web of Science ®Google Scholar
• Burdo JR, Menzies SL, Simpson IA, et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res. 2001;66(6):1198–1207. doi:10.1002/jnr.1256
   PubMed Web of Science ®Google Scholar
• Cheli VT, Correale J, Paez PM, Pasquini JM. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro. 2020;12:1759091420962681. doi:10.1177/1759091420962681
   Web of Science ®Google Scholar
• Wang XS, Ong WY, Connor JR. A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. J Neurocytol. 2001;30(4):353–360. doi:10.1023/a:1014464514793
   PubMedGoogle Scholar
• Skjorringe T, Burkhart A, Johnsen KB, Moos T. Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci. 2015;8:19. doi:10.3389/fnmol.2015.00019
   PubMed Web of Science ®Google Scholar
• Batista-Nascimento L, Pimentel C, Menezes RA, Rodrigues-Pousada C. Iron and neurodegeneration: from cellular homeostasis to disease. Oxid Med Cell Longev. 2012;2012:128647. doi:10.1155/2012/128647
   PubMed Web of Science ®Google Scholar
• Abdul Y, Li W, Ward R, et al. Deferoxamine treatment prevents post-stroke vasoregression and neurovascular unit remodeling leading to improved functional outcomes in type 2 male diabetic rats: role of endothelial ferroptosis. Transl Stroke Res. 2021;12(4):615–630. doi:10.1007/s12975-020-00844-7
   PubMed Web of Science ®Google Scholar
• Li W, Abdul Y, Chandran R, et al. Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. Am J Physiol Heart Circ Physiol. 2023;324(2):H212–H225. doi:10.1152/ajpheart.00490.2022
   PubMed Web of Science ®Google Scholar
• Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013;14(8):551–564. doi:10.1038/nrn3453
   PubMed Web of Science ®Google Scholar
• Pelizzoni I, Zacchetti D, Campanella A, Grohovaz F, Codazzi F. Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim Biophys Acta. 2013;1832(8):1326–1333. doi:10.1016/j.bbadis.2013.04.007
   PubMed Web of Science ®Google Scholar
• Moghaddam HK, Baluchnejadmojarad T, Roghani M, et al. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol Neurobiol. 2014;49(2):820–826. doi:10.1007/s12035-013-8559-7
   PubMed Web of Science ®Google Scholar
• Shen Z, Li ZY, Yu MT, Tan KL, Chen S. Metabolic perspective of astrocyte dysfunction in Alzheimer’s disease and type 2 diabetes brains. Bio Pharmacoth. 2023;158:114206. doi:10.1016/j.biopha.2022.114206
   PubMed Web of Science ®Google Scholar
• Lal A. Iron in health and disease: an update. Indian J Pediatr. 2020;87(1):58–65. doi:10.1007/s12098-019-03054-8
   PubMed Web of Science ®Google Scholar
• Zhang N, Yu X, Xie J, Xu H. New insights into the role of ferritin in iron homeostasis and neurodegenerative diseases. Mol Neurobiol. 2021;58(6):2812–2823. doi:10.1007/s12035-020-02277-7
   PubMed Web of Science ®Google Scholar
• Worwood M. Ferritin in human tissues and serum. Clin Haematol. 1982;11(2):275–307. doi:10.1016/S0308-2261(21)00338-6
   PubMedGoogle Scholar
• Powell LW, Alpert E, Isselbacher KJ, Drysdale JW. Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol. 1975;30(1):47–55. doi:10.1111/j.1365-2141.1975.tb00516.x
   PubMed Web of Science ®Google Scholar
• Connor JR, Menzies SL. Cellular management of iron in the brain. J Neurol Sci. 1995;134:33–44. doi:10.1016/0022-510x(95)00206-h
   PubMed Web of Science ®Google Scholar
• Qi Y, Dawson G. Hypoxia specifically and reversibly induces the synthesis of ferritin in oligodendrocytes and human oligodendrogliomas. J Neurochem. 1994;63(4):1485–1490. doi:10.1046/j.1471-4159.1994.63041485.x
   PubMed Web of Science ®Google Scholar
• Connor JR. Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction. Dev Neurosci. 1994;16(5–6):233–247. doi:10.1159/000112115
   PubMed Web of Science ®Google Scholar
• Guo G, Sun M, Li Y, et al. Serum ferritin has limited prognostic value on mortality risk in patients with decompensated cirrhosis: a propensity score matching analysis. Lab Med. 2023;54(1):47–55. doi:10.1093/labmed/lmac064
   PubMed Web of Science ®Google Scholar
• Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5(11):863–873. doi:10.1038/nrn1537
   PubMed Web of Science ®Google Scholar
• Zeinivand M, Nahavandi A, Baluchnejadmojarad T, Roghani M, Golab F. Dalteparin as a novel therapeutic agent to prevent diabetic encephalopathy by targeting oxidative stress and inflammation. Basic Clin Neurosci. 2020;11(6):795–804. doi:10.32598/bcn.11.6.1775.1
   PubMed Web of Science ®Google Scholar
• Jeong EA, Lee J, Shin HJ, et al. Tonicity-responsive enhancer-binding protein promotes diabetic neuroinflammation and cognitive impairment via upregulation of lipocalin-2. J Neuroinflammation. 2021;18(1):278. doi:10.1186/s12974-021-02331-8
   PubMed Web of Science ®Google Scholar
• Kim BW, Jeong KH, Kim JH, et al. Pathogenic upregulation of glial lipocalin-2 in the parkinsonian dopaminergic system. J Neurosci. 2016;36(20):5608–5622. doi:10.1523/JNEUROSCI.4261-15.2016
   PubMed Web of Science ®Google Scholar
• Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu Rev Nutr. 2017;37:103–130. doi:10.1146/annurev-nutr-071816-064559
   PubMed Web of Science ®Google Scholar
• Ma Z, Zhou Y, Xie J. Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats. Neurotox Res. 2012;22(4):274–279. doi:10.1007/s12640-012-9309-8
   PubMed Web of Science ®Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–7810. doi:10.1074/jbc.M008922200
   PubMed Web of Science ®Google Scholar
• Raha-Chowdhury R, Raha AA, Forostyak S, Zhao JW, Stott SR, Bomford A. Expression and cellular localization of hepcidin mRNA and protein in normal rat brain. BMC Neurosci. 2015;16:24. doi:10.1186/s12868-015-0161-7
   PubMed Web of Science ®Google Scholar
• Liu J, Hu X, Xue Y, et al. Targeting hepcidin improves cognitive impairment and reduces iron deposition in a diabetic rat model. Am J Transl Res. 2020;12(8):4830–4839.
   PubMed Web of Science ®Google Scholar
• Du F, Qian ZM, Luo Q, Yung WH, Ke Y. Hepcidin suppresses brain iron accumulation by downregulating iron transport proteins in iron-overloaded rats. Mol Neurobiol. 2015;52(1):101–114. doi:10.1007/s12035-014-8847-x
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–2093. doi:10.1126/science.1104742
   PubMed Web of Science ®Google Scholar
• Jiang F, Sun ZZ, Tang YT, Xu C, Jiao XY. Hepcidin expression and iron parameters change in Type 2 diabetic patients. Diabetes Res Clin Pract. 2011;93(1):43–48. doi:10.1016/j.diabres.2011.03.028
   PubMed Web of Science ®Google Scholar
• Sam AH, Busbridge M, Amin A, et al. Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med. 2013;30(12):1495–1499. doi:10.1111/dme.12262
   PubMed Web of Science ®Google Scholar
• Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci. 2008;9(1):36–45. doi:10.1038/nrn2294
   PubMed Web of Science ®Google Scholar
• Xiao Z, Shen D, Lan T, et al. Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice. Redox Biol. 2022;50:102256. doi:10.1016/j.redox.2022.102256
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998;21(1):62–68. doi:10.2337/diacare.21.1.62
   PubMed Web of Science ®Google Scholar
• Ferrannini E. Insulin resistance, iron, and the liver. Lancet. 2000;355(9222):2181–2182. doi:10.1016/S0140-6736(00)02397-7
   PubMed Web of Science ®Google Scholar
• Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab. 2010;298(6):E1236–43. doi:10.1152/ajpendo.00022.2010
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002;51(4):1000–1004. doi:10.2337/diabetes.51.4.1000
   PubMed Web of Science ®Google Scholar
• Houschyar KS, Ludtke R, Dobos GJ, et al. Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med. 2012;10:54. doi:10.1186/1741-7015-10-54
   PubMed Web of Science ®Google Scholar
• Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and cognitive impairment. Curr Diab Rep. 2016;16(9):87. doi:10.1007/s11892-016-0775-x
   PubMed Web of Science ®Google Scholar
• Nuzzo D, Picone P, Baldassano S, et al. Insulin resistance as common molecular denominator linking obesity to alzheimer’s disease. Curr Alzheimer Res. 2015;12(8):723–735. doi:10.2174/1567205012666150710115506
   PubMed Web of Science ®Google Scholar
• De Felice FG, Benedict C. A key role of insulin receptors in memory. Diabetes. 2015;64(11):3653–3655. doi:10.2337/dbi15-0011
   PubMed Web of Science ®Google Scholar
• Takechi R, Lam V, Brook E, et al. Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link. Front Aging Neurosci. 2017;9:399. doi:10.3389/fnagi.2017.00399
   PubMed Web of Science ®Google Scholar
• Chung JY, Kim HS, Song J. Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain. Biometals. 2018;31(5):705–714. doi:10.1007/s10534-018-0134-2
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, Wood JC. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2012;87(2):155–160. doi:10.1002/ajh.22223
   PubMed Web of Science ®Google Scholar
• Chen L, Li Y, Zhang F, Zhang S, Zhou X, Ji L. Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population. J Diabetes Complications. 2017;31(2):364–368. doi:10.1016/j.jdiacomp.2016.06.018
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol. 2014;2(6):513–526. doi:10.1016/S2213-8587(13)70174-8
   PubMed Web of Science ®Google Scholar
• Cerasuolo M, Di Meo I, Auriemma MC, et al. Iron and ferroptosis more than a suspect: beyond the most common mechanisms of neurodegeneration for new therapeutic approaches to cognitive decline and dementia. Int J Mol Sci. 2023;24(11):9637. doi:10.3390/ijms24119637
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang L, Tan YM, et al. Hepcidin gene silencing ameliorated inflammation and insulin resistance in adipose tissue of db/db mice via inhibiting METs formation. Mol Immunol. 2021;133:110–121. doi:10.1016/j.molimm.2021.02.015
   PubMed Web of Science ®Google Scholar
• Wang H, Li H, Jiang X, Shi W, Shen Z, Li M. Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats. Diabetes. 2014;63(5):1506–1518. doi:10.2337/db13-1195
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150. doi:10.1016/j.diabres.2014.04.006
   PubMed Web of Science ®Google Scholar
• Rom S, Zuluaga-Ramirez V, Gajghate S, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56(3):1883–1896. doi:10.1007/s12035-018-1195-5
   PubMed Web of Science ®Google Scholar
• Yun JH, Lee DH, Jeong HS, Kim HS, Ye SK, Cho CH. STAT3 activation in microglia exacerbates hippocampal neuronal apoptosis in diabetic brains. J Cell Physiol. 2021;236(10):7058–7070. doi:10.1002/jcp.30373
   PubMed Web of Science ®Google Scholar
• Lee HJ, Yang SJ. Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice. Int J Mol Sci. 2019;20:17.
   Web of Science ®Google Scholar
• Urrutia P, Aguirre P, Esparza A, et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem. 2013;126(4):541–549. doi:10.1111/jnc.12244
   PubMed Web of Science ®Google Scholar
• Rathore KI, Redensek A, David S. Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia. 2012;60(5):738–750. doi:10.1002/glia.22303
   PubMed Web of Science ®Google Scholar
• Wang J, Song N, Jiang H, Wang J, Xie J. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons. Biochim Biophys Acta. 2013;1832(5):618–625. doi:10.1016/j.bbadis.2013.01.021
   PubMed Web of Science ®Google Scholar
• Vela D. The dual role of hepcidin in brain iron load and inflammation. Front Neurosci. 2018;12:740. doi:10.3389/fnins.2018.00740
   PubMed Web of Science ®Google Scholar
• Zeinivand M, Nahavandi A, Zare M. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction. Inflammopharmacology. 2020;28(2):575–583. doi:10.1007/s10787-019-00665-7
   PubMed Web of Science ®Google Scholar
• Altamura S, Muckenthaler MU. Iron toxicity in diseases of aging: alzheimer’s disease, Parkinson’s disease and atherosclerosis. J Alzheimers Dis. 2009;16(4):879–895. doi:10.3233/JAD-2009-1010
   PubMed Web of Science ®Google Scholar
• Schroder N, Figueiredo LS, De lima MN. Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies. J Alzheimers Dis. 2013;34(4):797–812. doi:10.3233/JAD-121996
   PubMed Web of Science ®Google Scholar
• Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202(2):199–211. doi:10.1016/j.taap.2004.06.021
   PubMed Web of Science ®Google Scholar
• Stoyanovsky DA, Tyurina YY, Shrivastava I, et al. Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med. 2019;133:153–161. doi:10.1016/j.freeradbiomed.2018.09.008
   PubMed Web of Science ®Google Scholar
• Hoyos CM, Stephen C, Turner A, Ireland C, Naismith SL, Duffy SL. Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are at risk for dementia. Diabetes Res Clin Pract. 2022;184:109178. doi:10.1016/j.diabres.2021.109178
   PubMed Web of Science ®Google Scholar
• Clark GJ, Pandya K, Lau-Cam CA. The effect of metformin and taurine, alone and in combination, on the oxidative stress caused by diabetes in the rat brain. Adv Exp Med Biol. 2017;975(1):353–369. doi:10.1007/978-94-024-1079-2_31
   PubMedGoogle Scholar
• Marefati N, Abdi T, Beheshti F, Vafaee F, Mahmoudabady M, Hosseini M. Zingiber officinale (Ginger) hydroalcoholic extract improved avoidance memory in rat model of streptozotocin-induced diabetes by regulating brain oxidative stress. Horm Mol Biol Clin Investig. 2021;43(1):15–26. doi:10.1515/hmbci-2021-0033
   PubMed Web of Science ®Google Scholar
• Reus GZ, Dos Santos MA, Abelaira HM, et al. Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas. Diabetes Metab Res Rev. 2016;32(3):278–288. doi:10.1002/dmrr.2732
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5(5):561–568. doi:10.1097/00075197-200209000-00016
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148–160. doi:10.1038/s41583-019-0132-6
   PubMed Web of Science ®Google Scholar
• Pratico D, Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer’s disease. J Alzheimers Dis. 2004;6(2):171–175. doi:10.3233/jad-2004-6209
   PubMed Web of Science ®Google Scholar
• Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases. Redox Biol. 2021;41:101947. doi:10.1016/j.redox.2021.101947
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhang L, Xu Z, Chen W. Neurotoxic effects of iron overload under high glucose concentration. Neural Regen Res. 2013;8(36):3423–3433. doi:10.3969/j.issn.1673-5374.2013.36.008
   PubMed Web of Science ®Google Scholar
• Zhao M, Li XW, Chen Z, et al. Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Med Sci Monit. 2019;25:2186–2194. doi:10.12659/MSM.911250
   PubMed Web of Science ®Google Scholar
• Duzova H, Naziroglu M, Cig B, Gurbuz P, Akatli AN. Noopept attenuates diabetes-mediated neuropathic pain and oxidative hippocampal neurotoxicity via inhibition of TRPV1 channel in rats. Mol Neurobiol. 2021;58(10):5031–5051. doi:10.1007/s12035-021-02478-8
   PubMed Web of Science ®Google Scholar
• Yang XD, Yang YY. Ferroptosis as a novel therapeutic target for diabetes and its complications. Front Endocrinol (Lausanne). 2022;13:853822. doi:10.3389/fendo.2022.853822
   PubMed Web of Science ®Google Scholar
• Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res. 2021;2021:9999612. doi:10.1155/2021/9999612
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Sui X, Zhang R, Liu S, et al. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol. 2018;9:1371. doi:10.3389/fphar.2018.01371
   PubMed Web of Science ®Google Scholar
• Sumneang N, Siri-Angkul N, Kumfu S, Chattipakorn SC, Chattipakorn N. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes. Arch Biochem Biophys. 2020;680:108241. doi:10.1016/j.abb.2019.108241
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26(9):1021–1032. doi:10.1038/cr.2016.95
   PubMed Web of Science ®Google Scholar
• Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol. 2019;10:139. doi:10.3389/fphys.2019.00139
   PubMed Web of Science ®Google Scholar
• Guo T, Yu Y, Yan W, et al. Erythropoietin ameliorates cognitive dysfunction in mice with type 2 diabetes mellitus via inhibiting iron overload and ferroptosis. Exp Neurol. 2023;365:114414. doi:10.1016/j.expneurol.2023.114414
   PubMed Web of Science ®Google Scholar
• Chen J, Guo P, Han M, Chen K, Qin J, Yang F. Cognitive protection of sinomenine in type 2 diabetes mellitus through regulating the EGF/Nrf2/HO-1 signaling, the microbiota-gut-brain axis, and hippocampal neuron ferroptosis. Phytother Res. 2023;37:3323–3341. doi:10.1002/ptr.7807
   PubMed Web of Science ®Google Scholar
• Chen C, Huang Y, Xia P, et al. Long noncoding RNA Meg3 mediates ferroptosis induced by oxygen and glucose deprivation combined with hyperglycemia in rat brain microvascular endothelial cells, through modulating the p53/GPX4 axis. Eur J Histochem. 2021;65(3). doi:10.4081/ejh.2021.3224
   Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi:10.1080/01926230701320337
   PubMed Web of Science ®Google Scholar
• Hamed SA. Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol. 2017;10(4):409–428. doi:10.1080/17512433.2017.1293521
   PubMed Web of Science ®Google Scholar
• Kong FJ, Ma LL, Guo JJ, Xu LH, Li Y, Qu S. Endoplasmic reticulum stress/autophagy pathway is involved in diabetes-induced neuronal apoptosis and cognitive decline in mice. Clin Sci (Lond). 2018;132(1):111–125. doi:10.1042/CS20171432
   PubMed Web of Science ®Google Scholar
• Sadeghi A, Hami J, Razavi S, Esfandiary E, Hejazi Z. The effect of diabetes mellitus on apoptosis in hippocampus: cellular and molecular aspects. Int J Prev Med. 2016;7:57. doi:10.4103/2008-7802.178531
   PubMed Web of Science ®Google Scholar
• de Lima MN, Polydoro M, Laranja DC, et al. Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur J Neurosci. 2005;21(9):2521–2528. doi:10.1111/j.1460-9568.2005.04083.x
   PubMed Web of Science ®Google Scholar
• Hansen JB, Dos Santos LRB, Liu Y, et al. Glucolipotoxic conditions induce beta-cell iron import, cytosolic ROS formation and apoptosis. J Mol Endocrinol. 2018;61(2):69–77. doi:10.1530/JME-17-0262
   PubMed Web of Science ®Google Scholar
• Yun S, He X, Zhang W, Chu D, Feng C. Alleviation effect of grape seed proanthocyanidins on neuronal apoptosis in rats with iron overload. Biol Trace Elem Res. 2020;194(1):210–220. doi:10.1007/s12011-019-01766-8
   PubMed Web of Science ®Google Scholar
• Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10(11):969–977. doi:10.1016/S1474-4422(11)70188-0
   PubMed Web of Science ®Google Scholar
• Erus G, Battapady H, Zhang T, et al. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care. 2015;38(1):97–104. doi:10.2337/dc14-1196
   PubMed Web of Science ®Google Scholar
• Tella SH, Rendell MS. Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance. Ther Adv Endocrinol Metab. 2015;6(3):109–134. doi:10.1177/2042018815580257
   PubMed Web of Science ®Google Scholar
• Wicinski M, Socha M, Malinowski B, et al. Liraglutide and its neuroprotective properties-focus on possible biochemical mechanisms in alzheimer’s disease and cerebral ischemic events. Int J Mol Sci. 2019;20:5.
   Web of Science ®Google Scholar
• Zhang M, Yan W, Yu Y, et al. Liraglutide ameliorates diabetes-associated cognitive dysfunction via rescuing autophagic flux. J Pharmacol Sci. 2021;147(3):234–244. doi:10.1016/j.jphs.2021.07.004
   PubMed Web of Science ®Google Scholar
• Yang Y, Fang H, Xu G, et al. Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats. Mol Med Rep. 2018;18(2):2449–2457. doi:10.3892/mmr.2018.9180
   PubMed Web of Science ®Google Scholar
• Song JX, An JR, Chen Q, et al. Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice. Bioengineered. 2022;13(4):8334–8348. doi:10.1080/21655979.2022.2051858
   PubMed Web of Science ®Google Scholar
• Reus GZ, Bernardini Dos Santos MA, Abelaira HM, et al. Antioxidant therapy alters brain MAPK-JNK and BDNF signaling path-ways in experimental diabetes mellitus. Curr Neurovasc Res. 2016;13(2):107–114. doi:10.2174/1567202613666160219115832
   PubMed Web of Science ®Google Scholar
• Zeinivand M, Sharifi M, Hassanshahi G, Nedaei SE. Deferoxamine has the potential to improve the COVID-19-related inflammatory response in diabetic patients. Int J Pept Res Ther. 2023;29(4):63. doi:10.1007/s10989-023-10516-3
   PubMed Web of Science ®Google Scholar
• Hattori N, Schnell O, Bengel FM, et al. Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus. Eur J Nucl Med Mol Imaging. 2002;29(7):891–898. doi:10.1007/s00259-002-0799-0
   PubMed Web of Science ®Google Scholar
• Meng J, Zhu Y, Ma H, Wang X, Zhao Q. The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes. J Ethnopharmacol. 2021;280:114464. doi:10.1016/j.jep.2021.114464
   PubMed Web of Science ®Google Scholar
• Shi JJ, Liu HF, Hu T, et al. Danggui-Shaoyao-San improves cognitive impairment through inhibiting O-GlcNAc-modification of estrogen alpha receptor in female db/db mice. J Ethnopharmacol. 2021;281:114562. doi:10.1016/j.jep.2021.114562
   PubMed Web of Science ®Google Scholar
• Fu X, Liu Q, Sun X, Chang H, Liu Y, Han J. Research advances in the treatment of alzheimer’s disease with polysaccharides of danggui-shaoyao-san. J Alzheimers Dis. 2022;85(1):7–19. doi:10.3233/JAD-210656
   PubMed Web of Science ®Google Scholar
• Wang S, He B, Hang W, et al. Berberine alleviates tau hyperphosphorylation and axonopathy-associated with diabetic encephalopathy via Restoring PI3K/Akt/GSK3beta Pathway. J Alzheimers Dis. 2018;65(4):1385–1400. doi:10.3233/JAD-180497
   PubMed Web of Science ®Google Scholar
• Zhang JH, Zhang JF, Song J, et al. Effects of berberine on diabetes and cognitive impairment in an animal model: the mechanisms of action. Am J Chin Med. 2021;49(6):1399–1415. doi:10.1142/S0192415X21500658
   PubMedGoogle Scholar
• Wang Y, Yue S, Cai F, et al. Treatment of berberine alleviates diabetic nephropathy by reducing iron overload and inhibiting oxidative stress. Histol Histopathol. 2023:18599. doi:10.14670/HH-18-599
   Web of Science ®Google Scholar
• American Diabetes Association. 9. Professional practice committee: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S3. doi:10.2337/dc21-Sppc
   PubMedGoogle Scholar
• Wing RR, Look ARG. Does lifestyle intervention improve health of adults with overweight/obesity and type 2 diabetes? Findings from the Look AHEAD Randomized Trial. Obesity. 2021;29(8):1246–1258. doi:10.1002/oby.23158
   PubMed Web of Science ®Google Scholar
• Espeland MA, Luchsinger JA, Baker LD, et al. Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment. Neurology. 2017;88(21):2026–2035. doi:10.1212/WNL.0000000000003955
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol. 2018;14(11):653–666. doi:10.1038/s41582-018-0070-3
   PubMed Web of Science ®Google Scholar
• Palta P, Carlson MC, Crum RM, et al. Diabetes and cognitive decline in older adults: the ginkgo evaluation of memory study. J Gerontol a Biol Sci Med Sci. 2017;73(1):123–130. doi:10.1093/gerona/glx076
   PubMed Web of Science ®Google Scholar